Haemonetics CorporationHAENYSE
Loading
Year-over-year operating income growth rate
Percentile
P54
Within normal range
vs 2Y Ago
0.6x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 18.92% |
| Q3 2025 | 8.57% |
| Q2 2025 | -24.48% |
| Q1 2025 | 20.85% |
| Q4 2024 | 14.18% |
| Q3 2024 | 30.04% |
| Q2 2024 | 32.77% |
| Q1 2024 | -34.88% |
| Q4 2023 | 30.24% |
| Q3 2023 | -34.21% |
| Q3 2023 | 52.20% |
| Q1 2023 | -18.54% |
| Q4 2022 | -7.39% |
| Q4 2022 | 51.89% |
| Q3 2022 | 60.25% |
| Q1 2022 | -46.15% |
| Q1 2022 | 45.45% |
| Q4 2021 | 1663.31% |
| Q3 2021 | 106.56% |
| Q1 2021 | -152.38% |
| Q4 2020 | -31.23% |
| Q3 2020 | 401.77% |
| Q2 2020 | -54.95% |
| Q1 2020 | -36.42% |
| Q4 2019 | -17.76% |
| Q3 2019 | 473.92% |
| Q2 2019 | -155.76% |
| Q1 2019 | -15.76% |
| Q4 2018 | 8.61% |
| Q3 2018 | 392.65% |
| Q2 2018 | -62.92% |
| Q1 2018 | 1309.18% |
| Q4 2017 | -95.82% |
| Q3 2017 | 46.04% |
| Q3 2017 | 128.89% |
| Q1 2017 | -371.10% |
| Q4 2016 | -14.45% |
| Q4 2016 | 414.60% |
| Q3 2016 | -42.00% |
| Q1 2016 | 90.93% |